No Cracks In Antitrust Suit Against Biogen, Rival Argues
Ixchel Pharma LLC on Friday told a California federal court it had already suffered financial losses due to rival Biogen Inc.'s alleged anti-competitive scheme to undermine its development of a treatment...To view the full article, register now.
Already a subscriber? Click here to view full article